Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearingDIANE Publishing |
Términos y frases comunes
180-day exclusivity agree Agreements Filed ANDA anticompetitive antitrust laws Antitrust Litigation applicant Barr Barr Pharmaceuticals benefit Best Buy Drugs Billy Tauzin blockbuster drugs brand company brand name brand-name company brand-name drug bright-line rule Cardizem Cephalon Committee compete competitor Congress Consumer Reports Consumers Union costs court decisions delay Downey drug companies early entry effect Eleventh Circuit enter the market entry date ESupp.2d exclusion payment settlements exclusivity period FDA approval Federal Trade Commission filer FTC's generic's Grassley Hatch-Waxman Act Hatch-Waxman settlements incentive innovator invalid involving issue Lansoprazole lawsuit manufacturer Medicare Prescription Drug medicines million Modernization Act Name Drugs parties patent challenges patent dispute patent expiration patent holder patent infringement patent position patent settlements percent pharmaceutical companies pharmaceutical industry PhRMA potential profits Prohibited question reverse payment settlements Schering Schering-Plough Senator HATCH Senator KOHL settlement agreements Tamoxifen Tamoxifen Citrate Tauzin Terazosin testimony Thank Upsher Valley Drug Wroblewski
Pasajes populares
Página 55 - The aim and result of every price-fixing agreement, if effective, is the elimination of one form of competition. The power to fix prices, whether reasonably exercised or not, involves power to control the market and to fix arbitrary and unreasonable prices.
Página 55 - Agreements which create such potential power may well be held to be in themselves unreasonable or unlawful restraints, without the necessity of minute inquiry whether a particular price is reasonable or unreasonable as fixed and without placing on the government in enforcing the Sherman Law the burden of ascertaining from day to day whether it has become unreasonable through the mere variation of economic conditions.
Página 55 - However, there are certain agreements or practices which because of their pernicious effect on competition and lack of any redeeming virtue are conclusively presumed to be unreasonable and therefore illegal without elaborate inquiry as to the precise harm they have caused or the business excuse for their use.
Página 121 - This written statement represents the views of the Federal Trade Commission. My oral presentation and responses to questions are my own, and do not necessarily represent the views of the Commission or any other Commissioner.
Página 6 - I can' swear you in. Do you swear that the testimony you are about to give to the Subcommittee will be the truth, the whole truth, and nothing but the truth, so help you, God?
Página 121 - Deborah Platt Majoras, Chairman of the Federal Trade Commission.' I appreciate the opportunity to appear before you today to discuss the laws currently applicable to resellers of consumer information, commonly known as "data brokers.
Página 16 - Do you solemnly swear that the testimony you are about to give before this committee will be the truth, the whole truth, and nothing hut the truth, so help you God ? Mr.
Página 77 - The Federal Trade Commission and the Antitrust Division of the Department of Justice will continue active programs of enforcement of the antitrust laws in the energy industries.
Página 101 - Ford, he again returned to private law practice as a partner in the Washington, DC office of the law firm of Mays, Valentine, Davenport and Moore of Richmond, Virginia.